中文产业新闻评分60Chinese source
《Cell》发表糖萼编辑MSC首个人体I期试验：单次输注使晚期骨质疏松患者骨折风险降94%
《Cell》: 一针输注，骨折风险直降94%
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
《Cell》: 一针输注，骨折风险直降94%
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.